![Troy Ignelzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Troy Ignelzi
Director of Finance/CFO at
RAPPORT THERAPEUTICS, INC.
Net worth: 486 700 $ as of 2026-08-30
Profile
Mr. Troy A. Ignelzi is an Independent Director at Harmony Biosciences Holdings, Inc., an Independent Director at Contineum Therapeutics, Inc., a Chief Financial Officer at Rapport Therapeutics, Inc., an Executive Advisor at Sofinnova Investments, Inc. and an Independent Director at Abivax SA. He is on the Board of Directors at Harmony Biosciences Holdings, Inc., Contineum Therapeutics, Inc. and Abivax SA.
Mr. Ignelzi was previously employed as an Independent Director by CinCor Pharma, Inc., a Chairman by Vedanta Biosciences, Inc., a Chief Financial Officer by Karuna Therapeutics, Inc., a Chief Financial & Accounting Officer by scPharmaceuticals, Inc., a Chief Financial Officer by Juventas Therapeutics, Inc., a Senior VP-Operations & Business Development by PharmaLex GmbH, a Vice President by Esperion Therapeutics, Inc., and a VP-Business Development & Strategic Planning by InSys Therapeutics, Inc. /Old/.
He received his undergraduate degree from Ferris State University (Michigan).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-13 | 10,000 ( 0.02% ) | 486 700 $ | 2026-08-30 | |
| 2026-06-25 | 0 ( -.--% ) | - $ | 2026-08-30 | |
| 2026-04-01 | 0 ( -.--% ) | - $ | 2026-08-30 | |
ABIVAX SA -.--% | 2026-02-27 | 0 ( -.--% ) | - $ | 2026-08-30 |
Troy Ignelzi active positions
| Companies | Position | Start |
|---|---|---|
| ABIVAX | Director/Board Member | 2023-07-10 |
| RAPPORT THERAPEUTICS, INC. | Director of Finance/CFO | 2023-10-31 |
| CONTINEUM THERAPEUTICS, INC. | Director/Board Member | 2024-05-19 |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Director/Board Member | 2026-04-01 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 2023-10-31 |
Former positions of Troy Ignelzi
| Companies | Position | End |
|---|---|---|
| KARA THER | Director of Finance/CFO | 2023-09-28 |
| CINCOR PHARMA, INC. | Director/Board Member | 2023-02-23 |
| SCPHARMACEUTICALS INC. | Director of Finance/CFO | 2019-02-27 |
Juventas Therapeutics, Inc.
 Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Director of Finance/CFO | 2016-01-31 |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Troy Ignelzi
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Ferris State University (Michigan)
 Ferris State University (Michigan) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InSys Therapeutics, Inc. /Old/
 InSys Therapeutics, Inc. /Old/ Pharmaceuticals: GenericHealth Technology Manufactures pharmaceutical products | Health Technology |
Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Health Services |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines for psychiatric and neurological disorders like schizophrenia and Alzheimer’s disease | Health Technology |
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
PharmaLex GmbH
 PharmaLex GmbH Packaged SoftwareTechnology Services Develops AI and machine learning automation for pharmacy, biotech & med tech industries | Technology Services |
Harmony Biosciences Holdings, Inc.
 Harmony Biosciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for patients living with rare neurological disorders | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
- Stock Market
- Insiders
- Troy Ignelzi
